ChemicalBook >> CAS DataBase List >>Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-

CAS No.
2748157-34-6
Chemical Name:
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-
Synonyms
2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid;Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-
CBNumber:
CB813187534
Molecular Formula:
C20H25N3O5
Molecular Weight:
387.43
MDL Number:
MOL File:
2748157-34-6.mol
Last updated:2023-06-08 09:03:09
Product description Number Pack Size Price
AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 17084 500 μg $117
AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 17084 1 mg $222
AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 17084 5 mg $923

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Properties

Boiling point 643.3±50.0 °C(Predicted)
Density 1.41±0.1 g/cm3(Predicted)
solubility DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 3 mg/ml
pka 3.18±0.25(Predicted)

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 17084 AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 2748157-34-6 500 μg $117 2024-03-01 Buy
Cayman Chemical 17084 AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 2748157-34-6 1 mg $222 2024-03-01 Buy
Cayman Chemical 17084 AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) 2748157-34-6 5 mg $923 2024-03-01 Buy
Product number Packaging Price Buy
17084 500 μg $117 Buy
17084 1 mg $222 Buy
17084 5 mg $923 Buy

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Chemical Properties,Uses,Production

Description

AB-CHMINACA is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA , a potent agonist of the central CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M7 is a potential metabolite produced during metabolism of AB-CHMINACA in vivo. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

References

1. Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products Forensic Toxicol. 31(1),93-100(2013).
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives ,1-283(2009).

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Preparation Products And Raw materials

Raw materials

Preparation Products

Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
Cayman Chemical Company 800-364-9897 sales@caymanchem.com China 6838 58
Supplier Advantage
Cayman Chemical Company 58
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid 2748157-34-6